Luisa María Villar

Universidad de Alcalá

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

80%

Virology

40%

Multiple Sclerosis

80%

Inflammatory Biology

40%

Neuroinflammation

40%

Immunomodulation

40%

Biomarker Research

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

Article Link

Year:

2024

Establishing Normal Serum Values of Neurofilament Light Chains and Glial Fibrillary Acidic Protein Considering the Effects of Age and Other Demographic Factors in Healthy Adults

Article Link

Year:

2024

MIND Diet Impact on Multiple Sclerosis Patients: Biochemical Changes after Nutritional Intervention

Article Link

Year:

2024

Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis

Article Link

Year:

2024

Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis

Article Link

Year:

2024

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis

Article Link

Year:

2024

Factors Associated with SARS-CoV-2 Infection in Fully Vaccinated Nursing Home Residents and Workers

Article Link

Year:

2024

Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine

Article Link

Year:

2023

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure

Article Link

Year:

2023

Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Article Link

Year:

2023

Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non‐cell‐autonomous neuronal damage

Article Link

Year:

2022

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

Article Link

Year:

2021

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients.

Article Link

Year:

2020

Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers

Article Link

Year:

2020

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Article Link

Year:

2020

Collaborators8

Avril Robertson

Affiliate Professor

University of Queensland

AUSTRALIA

Angel Torrado-Carvajal

Assistant Professor

Universidad Rey Juan Carlos

SPAIN

Enric Monreal

Healthcare professional

HOSPITAL UNIVERSITARIO RAMÓN Y CAJAL

SPAIN

Francisco Pérez-Miralles

Associate Lecturer in Anatomy, Physiology and Neurology of voice, speech and language

University of Valencia

SPAIN

Javier Caballero-Villarraso

SPAIN

Manuel Comabella

SPAIN

Maria Buxó Pujolràs

Institut de Recerca Biomèdica de Lleida

SPAIN

Koen Vandenbroeck

Ikerbasque Research Professor / Dir. Neurogenomiks

Ikerbasque, Basque Foundation for Science

SPAIN

How do I reach out?

Meet Kite AI